Traws Pharma
TRAW0.51940.12% ( -0.0006 )
Traws Pharma (TRAW)
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is dev...
- Open
- 0.5320
- High
- 0.5354
- Low
- 0.5066
- Prev. Close
- 0.5200
- Volume
- 17.92K
- Turnover
- 9.29K
- Avg Price
- 0.5187
- Bid/Ask Ratio
- --
- Amplitude
- 5.54%
- 52wk High
- 3.2650
- Volume Ratio
- 0.27
- Turnover Ratio
- 0.25%
Traws Pharma Analyst Rating
View MoreForecast & Rating
Jun 22, 2026Price forecast
$1.0092.57%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 10 at 03:04 PM
Traws Pharma launches at-the-market offering of up to $5.58 million in shares
- PUBT · Jul 9 at 03:02 PM
Traws Pharma holds annual shareholder meeting in virtual format
- PUBT · Jun 22 at 06:02 AM
Traws Pharma targets 3Q 2026 MHRA resubmission to advance TXM Phase 2a influenza challenge study
- benzinga_article · Jun 18 at 07:10 AM
This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
- benzinga_article · Jun 15 at 12:05 PM
12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga_article · Jun 15 at 10:10 AM
Traws Pharma Stock Falls As UK Regulator Delays Key Flu Study
